Machina Capital’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-14,848
Closed -$1.65M 379
2025
Q3
$1.65M Buy
+14,848
New +$1.69M 0.29% 124
2025
Q2
Sell
-6,484
Closed -$727K 352
2025
Q1
$727K Sell
6,484
-10,826
-63% -$1.12M 0.22% 157
2024
Q4
$1.6M Buy
17,310
+2,071
+14% +$186K 0.67% 41
2024
Q3
$1.28M Sell
15,239
-3,708
-20% -$283K 0.51% 67
2024
Q2
$1.3M Buy
18,947
+1,731
+10% +$116K 0.58% 48
2024
Q1
$1.26M Buy
17,216
+5,217
+43% +$401K 0.66% 36
2023
Q4
$972K Sell
11,999
-2,177
-15% -$169K 0.63% 42
2023
Q3
$1.06M Buy
+14,176
New +$1.09M 0.6% 49
2022
Q4
Sell
-3,519
Closed -$217K 174
2022
Q3
$217K Sell
3,519
-2,005
-36% -$126K 0.46% 119
2022
Q2
$341K Buy
+5,524
New +$342K 0.77% 60
2021
Q3
Sell
-5,200
Closed -$358K 157
2021
Q2
$358K Buy
+5,200
New +$347K 0.61% 69
2019
Q4
Sell
-15,511
Closed -$983K 388
2019
Q3
$983K Buy
15,511
+10,637
+218% +$695K 0.45% 69
2019
Q2
$329K Sell
4,874
-12,383
-72% -$815K 0.12% 205
2019
Q1
$1.12M Buy
17,257
+6,197
+56% +$412K 0.45% 80
2018
Q4
$692K Buy
+11,060
New +$773K 0.46% 86

Other funds holding GILD

Machina Capital's GILD Position: Q4 2025 in Review

Machina Capital sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 14,848 shares — an estimated $1.65M sold.

Machina Capital first reported a position in GILD in Q4 2018 and held it in 15 quarters. The position peaked at $1.65M in Q3 2025. 2,220 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • Machina Capital reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
  • Machina Capital sold 14,848 Gilead Sciences shares in Q4 2025, an estimated $1.65M.
  • Machina Capital first reported a position in Gilead Sciences in Q4 2018 and held it in 15 quarters.
  • Machina Capital's Gilead Sciences position peaked at $1.65M in Q3 2025.
  • 2,220 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Machina Capital's 13F filing for Q4 2025, filed 10 Feb 2026.